TB and Sarcoidosis Granuloma
NCT06396910 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2024-05-02
Summary
Tuberculosis (TB) and sarcoidosis are both granulomatous diseases. Here we compared the immunological micro-environments of granulomas from TB and sarcoidosis patients using in situ sequencing (ISS) transcriptomic analysis and multiplexed immunolabelling of tissue sections.
Conditions
- Tuberculosis
- Sarcoidosis
Interventions
- DIAGNOSTIC_TEST
-
Spatial transcriptomics
Localize immune transcripts in the pulmonary lessions of sarcoidosis and tuberculosis patients. This is done in biopsies from pathological libraries.
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 10 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2022-09-01
- Completion
- 2023-07-01
Countries
- Sweden
Study Locations
More Related Trials
-
Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis
NCT00285441 ·Status: UNKNOWN
-
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
NCT05621343 ·Status: RECRUITING
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Evaluation of Tuberculosis Treatment Outcomes
NCT06942975 ·Status: COMPLETED
-
Immunobiology of Diabetes and Tuberculosis
NCT00568854 ·Status: TERMINATED ·Phase: NA
-
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
NCT06728930 ·Status: ENROLLING_BY_INVITATION
-
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
NCT01099098 ·Status: COMPLETED
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
Follow up of Autoantibodies in Active Tuberculosis
NCT00551226 ·Status: UNKNOWN
-
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
NCT06764576 ·Status: RECRUITING
-
Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
NCT06709157 ·Status: NOT_YET_RECRUITING
-
Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF
NCT01371916 ·Status: COMPLETED
-
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
NCT01269268 ·Status: COMPLETED
-
Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients
NCT00962676 ·Status: COMPLETED
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Innovation in Tuberculosis
NCT04002869 ·Status: UNKNOWN
-
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
NCT01424501 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
NCT00692809 ·Status: UNKNOWN
-
Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate
NCT06141148 ·Status: RECRUITING
-
Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
NCT02503839 ·Status: COMPLETED ·Phase: PHASE1
-
Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung
NCT05027958 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis
NCT01252992 ·Status: COMPLETED
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals
NCT00707317 ·Status: COMPLETED
-
Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy
NCT00811343 ·Status: COMPLETED ·Phase: NA